USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
ArunA Biomedical, Inc.
Address:
425 River Road
Athens, GA 30602-
Phone:
(706) 542-9191
URL:
EIN:
550899162
DUNS:
170950476
Number of Employees:
7
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $1,160,565.00 4
SBIR Phase II $300,000.00 1

Award List:

Adhesion Signature-Based, Label-Free Isolation of Pluripotent Stem Cell Derived N

Award Year / Program / Phase:
2012 / SBIR / Phase I
Award Amount:
$706,226.00
Agency:
HHS
Principal Investigator:
Jamie M. Chilton – 706-542-9191
Abstract:
DESCRIPTION (provided by applicant): Currently, up to one billion people worldwide suffer from disabling neurodegenerative disorders, including traumatic injuries, stroke and diseases of the CNS such as Alzheimer's and Parkinson's disease (PD). As the number of afflicted individuals… More

Developmental Neurotox Assay Using Scalable Neupons and Astrocytes in High Content Imaging

Award Year / Program / Phase:
2013 / SBIR / Phase I
Award Amount:
$79,993.00
Agency:
EPA
Principal Investigator:
Steven Stice – 706-583-0071
Abstract:
The objective of this proposed project and the EPA Computational Toxicology program’s goals are aligned in assessing chemicals for potential risk to human health and the environment through the use of more representative multicellular human developmental neurotoxicology assays. ArunA Biomedical… More

Novel Assays for Screening the Effects of Chemical Toxicants on Cell Differentiat

Award Year / Program / Phase:
2013 / SBIR / Phase I
Award Amount:
$224,956.00
Agency:
HHS
Principal Investigator:
Jamie M. Chilton – 706-542-4941
Abstract:
SUMMARY The overarching objective of this Phase I project is to determine the feasibility of developing both focused and broad toxicity metabolomic assays for three neural development associated windows of susceptibility (WOS) for human development. Epidemiological and laboratory studies have… More

SBIR Phase I: Physical Cellular High Content Screening Using a piggyBac Transposen System

Award Year / Program / Phase:
2013 / SBIR / Phase I
Award Amount:
$149,390.00
Agency:
NSF
Principal Investigator:
Abstract:
This Small Business Innovation Research (SBIR) Phase I project will address the demand for new and evolving approaches to alleviate shrinking drug pipelines and costly failed human safety trials and recalls by implementation of new technologies to transform complex human stem cell-derived neural… More

Developmental Neurotox Assay using Scalable Neurons and Astrocytes in High Content Imaging

Award Year / Program / Phase:
2014 / SBIR / Phase II
Award Amount:
$300,000.00
Agency:
EPA
Principal Investigator:
Anirban Majumder – (706) 542-9191
Abstract:
There is unmet need for rapid, cost effective in vitro methods to identify chemicals that pose a hazard to the human brain. A number of in vitro assays utilizing primary cells have been tested in an effort to devise effective models to prioritize chemicals for further in depth toxicity studies.… More